Top compounds associated with response to LYPD2


Feature Type Standardized
Nominal ANOVA
mRNA SN-38 GDSC1000 pan-cancer AAC -0.08 0.02
mRNA SB 505124 GDSC1000 pan-cancer AAC -0.08 0.02
mRNA AT-406 CTRPv2 pan-cancer AAC 0.11 0.02
mRNA Erlotinib UHNBreast pan-cancer AAC 0.6 0.02
mRNA SB-525334 CTRPv2 pan-cancer AAC 0.081 0.03
mRNA CAY10603 GDSC1000 pan-cancer AAC -0.067 0.03
mRNA XAV-939 GDSC1000 pan-cancer AAC -0.076 0.03
mRNA Docetaxel GDSC1000 pan-cancer AAC -0.069 0.03
mRNA BRD-K29086754 CTRPv2 pan-cancer AAC 0.16 0.03
mRNA pitstop2 CTRPv2 pan-cancer AAC 0.097 0.03
Download CSV